chr6-35944295-G-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting
The NM_052961.4(SLC26A8):c.2518C>A(p.Gln840Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000109 in 1,613,510 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052961.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC26A8 | NM_052961.4 | c.2518C>A | p.Gln840Lys | missense_variant | 20/20 | ENST00000490799.6 | NP_443193.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A8 | ENST00000490799.6 | c.2518C>A | p.Gln840Lys | missense_variant | 20/20 | 1 | NM_052961.4 | ENSP00000417638 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151800Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251176Hom.: 0 AF XY: 0.0000958 AC XY: 13AN XY: 135766
GnomAD4 exome AF: 0.000117 AC: 171AN: 1461710Hom.: 0 Cov.: 31 AF XY: 0.000122 AC XY: 89AN XY: 727156
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151800Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74128
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2023 | The c.2518C>A (p.Q840K) alteration is located in exon 20 (coding exon 19) of the SLC26A8 gene. This alteration results from a C to A substitution at nucleotide position 2518, causing the glutamine (Q) at amino acid position 840 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at